Cargando…

Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels

BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) proteins form non-selective but calcium-permeable membrane channels, rapidly activated by extracellular application of the steroid pregnenolone sulphate and the dihydropyridine nifedipine. Our aim was to characterize the stero...

Descripción completa

Detalles Bibliográficos
Autores principales: Drews, A, Mohr, F, Rizun, O, Wagner, T F J, Dembla, S, Rudolph, S, Lambert, S, Konrad, M, Philipp, S E, Behrendt, M, Marchais-Oberwinkler, S, Covey, D F, Oberwinkler, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925040/
https://www.ncbi.nlm.nih.gov/pubmed/24251620
http://dx.doi.org/10.1111/bph.12521
_version_ 1782303803510358016
author Drews, A
Mohr, F
Rizun, O
Wagner, T F J
Dembla, S
Rudolph, S
Lambert, S
Konrad, M
Philipp, S E
Behrendt, M
Marchais-Oberwinkler, S
Covey, D F
Oberwinkler, J
author_facet Drews, A
Mohr, F
Rizun, O
Wagner, T F J
Dembla, S
Rudolph, S
Lambert, S
Konrad, M
Philipp, S E
Behrendt, M
Marchais-Oberwinkler, S
Covey, D F
Oberwinkler, J
author_sort Drews, A
collection PubMed
description BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) proteins form non-selective but calcium-permeable membrane channels, rapidly activated by extracellular application of the steroid pregnenolone sulphate and the dihydropyridine nifedipine. Our aim was to characterize the steroid binding site by analysing the structural chemical requirements for TRPM3 activation. EXPERIMENTAL APPROACH: Whole-cell patch-clamp recordings and measurements of intracellular calcium concentrations were performed on HEK293 cells transfected with TRPM3 (or untransfected controls) during superfusion with pharmacological substances. KEY RESULTS: Pregnenolone sulphate and nifedipine activated TRPM3 channels supra-additively over a wide concentration range. Other dihydropyridines inhibited TRPM3 channels. The natural enantiomer of pregnenolone sulphate was more efficient in activating TRPM3 channels than its synthetic mirror image. However, both enantiomers exerted very similar inhibitory effects on proton-activated outwardly rectifying anion channels. Epiallopregnanolone sulphate activated TRPM3 almost equally as well as pregnenolone sulphate. Exchanging the sulphate for other chemical moieties showed that a negative charge at this position is required for activating TRPM3 channels. CONCLUSIONS AND IMPLICATIONS: Our data demonstrate that nifedipine and pregnenolone sulphate act at different binding sites when activating TRPM3. The latter activates TRPM3 by binding to a chiral and thus proteinaceous binding site, as inferred from the differential effects of the enantiomers. The double bond between position C5 and C6 of pregnenolone sulphate is not strictly necessary for the activation of TRPM3 channels, but a negative charge at position C3 of the steroid is highly important. These results provide a solid basis for understanding mechanistically the rapid chemical activation of TRPM3 channels.
format Online
Article
Text
id pubmed-3925040
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher John Wiley & Sons Ltd
record_format MEDLINE/PubMed
spelling pubmed-39250402014-12-31 Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels Drews, A Mohr, F Rizun, O Wagner, T F J Dembla, S Rudolph, S Lambert, S Konrad, M Philipp, S E Behrendt, M Marchais-Oberwinkler, S Covey, D F Oberwinkler, J Br J Pharmacol Research Papers BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) proteins form non-selective but calcium-permeable membrane channels, rapidly activated by extracellular application of the steroid pregnenolone sulphate and the dihydropyridine nifedipine. Our aim was to characterize the steroid binding site by analysing the structural chemical requirements for TRPM3 activation. EXPERIMENTAL APPROACH: Whole-cell patch-clamp recordings and measurements of intracellular calcium concentrations were performed on HEK293 cells transfected with TRPM3 (or untransfected controls) during superfusion with pharmacological substances. KEY RESULTS: Pregnenolone sulphate and nifedipine activated TRPM3 channels supra-additively over a wide concentration range. Other dihydropyridines inhibited TRPM3 channels. The natural enantiomer of pregnenolone sulphate was more efficient in activating TRPM3 channels than its synthetic mirror image. However, both enantiomers exerted very similar inhibitory effects on proton-activated outwardly rectifying anion channels. Epiallopregnanolone sulphate activated TRPM3 almost equally as well as pregnenolone sulphate. Exchanging the sulphate for other chemical moieties showed that a negative charge at this position is required for activating TRPM3 channels. CONCLUSIONS AND IMPLICATIONS: Our data demonstrate that nifedipine and pregnenolone sulphate act at different binding sites when activating TRPM3. The latter activates TRPM3 by binding to a chiral and thus proteinaceous binding site, as inferred from the differential effects of the enantiomers. The double bond between position C5 and C6 of pregnenolone sulphate is not strictly necessary for the activation of TRPM3 channels, but a negative charge at position C3 of the steroid is highly important. These results provide a solid basis for understanding mechanistically the rapid chemical activation of TRPM3 channels. John Wiley & Sons Ltd 2014-02 2014-01-24 /pmc/articles/PMC3925040/ /pubmed/24251620 http://dx.doi.org/10.1111/bph.12521 Text en Copyright © 2013 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society. https://creativecommons.org/licenses/by-nc-nd/3.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Papers
Drews, A
Mohr, F
Rizun, O
Wagner, T F J
Dembla, S
Rudolph, S
Lambert, S
Konrad, M
Philipp, S E
Behrendt, M
Marchais-Oberwinkler, S
Covey, D F
Oberwinkler, J
Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels
title Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels
title_full Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels
title_fullStr Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels
title_full_unstemmed Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels
title_short Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels
title_sort structural requirements of steroidal agonists of transient receptor potential melastatin 3 (trpm3) cation channels
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925040/
https://www.ncbi.nlm.nih.gov/pubmed/24251620
http://dx.doi.org/10.1111/bph.12521
work_keys_str_mv AT drewsa structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT mohrf structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT rizuno structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT wagnertfj structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT demblas structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT rudolphs structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT lamberts structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT konradm structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT philippse structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT behrendtm structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT marchaisoberwinklers structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT coveydf structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels
AT oberwinklerj structuralrequirementsofsteroidalagonistsoftransientreceptorpotentialmelastatin3trpm3cationchannels